When.com Web Search

  1. Ads

    related to: dvd for myeloma treatment options after relapse removal cost 1

Search results

  1. Results From The WOW.Com Content Network
  2. Lenalidomide - Wikipedia

    en.wikipedia.org/wiki/Lenalidomide

    Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone. [8] It is taken by mouth. [8]

  3. Elranatamab - Wikipedia

    en.wikipedia.org/wiki/Elranatamab

    The safety and effectiveness of elranatamab was evaluated in MagnetisMM-3 (NCT04649359), an open-label, single-arm, multi-center study that included participants with relapsed/refractory multiple myeloma who are refractory to at least one proteasome inhibitor, one immunomodulatory drug, and one anti-CD38 antibody. [12]

  4. Belantamab mafodotin - Wikipedia

    en.wikipedia.org/wiki/Belantamab_mafodotin

    Belantamab mafodotin is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent.

  5. Multiple myeloma gets new attention after Bruce ... - AOL

    www.aol.com/news/multiple-myeloma-gets-attention...

    Doctors said that’s a result of better treatment options, and may even be an underestimate given the new drugs available. In many cases, people with multiple myeloma are still able to pursue ...

  6. Ixazomib - Wikipedia

    en.wikipedia.org/wiki/Ixazomib

    Takeda submitted a US new drug application for multiple myeloma in July 2015. [15] In September 2015, the U.S. Food and Drug Administration (FDA) granted ixazomib combined with lenalidomide and dexamethasone a priority review designation for multiple myeloma. [16] On 20 November 2015, the FDA approved this combination for second-line treatment. [7]

  7. Graft-versus-tumor effect - Wikipedia

    en.wikipedia.org/wiki/Graft-versus-tumor_effect

    Graft-versus-tumor effect (GvT) appears after allogeneic hematopoietic stem cell transplantation (HSCT). The graft contains donor T cells (T lymphocytes) that can be beneficial for the recipient by eliminating residual malignant cells. [1] GvT might develop after recognizing tumor-specific or recipient-specific alloantigens.

  1. Ad

    related to: dvd for myeloma treatment options after relapse removal cost 1